Literature DB >> 36083421

Inferring meaningful change in quality of life with posterior predictive distribution: an alternative to standard error of measurement.

Yuelin Li1.   

Abstract

OBJECTIVE: In the absence of population-based information, distribution-based meaningful change metrics have been previously found to perform similarly. Yet, it is unknown how a Bayesian approach derived from Posterior Predictive Distribution (PPD) of anticipated changes would compare against existing metrics.
METHODS: PPD defines meaningful change as change scores that exceed the amount expected from the posterior predictive distribution given a previous score. The PPD adjusts for common statistical phenomena that arise in a pre-test-post-test setting, such as regression to the mean and post-test drift. The PPD was compared to Reliable Change Index (RCI) and Gulliksen-Lord-Novick (GLN) methods using published real-world data and simulated hypothetical data, respectively.
RESULTS: Real-world data showed that the methods made similar classifications when the measurement reliability was above 0.80. When reliability was low at 0.50 and thus more susceptible to regression to the mean effects, PPD and GLN were able to correct for it but not the RCI. However, PPD was more conservative and sensitive to biased priors. The simulation study showed that the three methods performed similarly overall, but PPD was slightly better in detecting prevalent changes, e.g., at time 2 (against RCI at p < 0.0001; against GLN at p < 0.0001) and time 3 (p = 0.024, p = 0.002).
CONCLUSIONS: When measurement reliability is high, as is frequent in HRQOL development efforts, the three methods performed similarly. At a cost of more conservative cutoffs and complex calculations, the Bayesian PPD nevertheless confers practical advantages when reliability is low. It may be worthy of further research and applications.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Bayesian posterior predictive distribution; Bayesian regression; Bayesian statistics; meaningful change

Year:  2022        PMID: 36083421     DOI: 10.1007/s11136-022-03239-3

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   3.440


  22 in total

1.  Clinical significance methods: a comparison of statistical techniques.

Authors:  Stephanie Bauer; Michael J Lambert; Steven Lars Nielsen
Journal:  J Pers Assess       Date:  2004-02

2.  Clinical significance: a statistical approach to defining meaningful change in psychotherapy research.

Authors:  N S Jacobson; P Truax
Journal:  J Consult Clin Psychol       Date:  1991-02

3.  Assessing clinical significance: does it matter which method we use?

Authors:  David C Atkins; Jamie D Bedics; Joseph B McGlinchey; Theodore P Beauchaine
Journal:  J Consult Clin Psychol       Date:  2005-10

4.  Clinical significance of patient-reported questionnaire data: another step toward consensus.

Authors:  Jeff A Sloan; David Cella; Ron D Hays
Journal:  J Clin Epidemiol       Date:  2005-10-13       Impact factor: 6.437

5.  Combining distribution- and anchor-based approaches to determine minimally important differences: the FACIT experience.

Authors:  Kathleen J Yost; David T Eton
Journal:  Eval Health Prof       Date:  2005-06       Impact factor: 2.651

Review 6.  The clinical significance of quality of life assessments in oncology: a summary for clinicians.

Authors:  Jeff A Sloan; Marlene H Frost; Rick Berzon; Amylou Dueck; Gordon Guyatt; Carol Moinpour; Mirjam Sprangers; Carol Ferrans; David Cella
Journal:  Support Care Cancer       Date:  2006-06-23       Impact factor: 3.603

7.  A multiperspective, multivariable evaluation of reliable change.

Authors:  K M Lunnen; B M Ogles
Journal:  J Consult Clin Psychol       Date:  1998-04

8.  Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer.

Authors:  Jammbe Z Musoro; Corneel Coens; Susanne Singer; Silke Tribius; Sjoukje F Oosting; Mogens Groenvold; Christian Simon; Jean-Pascal Machiels; Vincent Grégoire; Galina Velikova; Kim Cocks; Mirjam A G Sprangers; Madeleine T King; Andrew Bottomley
Journal:  Head Neck       Date:  2020-07-06       Impact factor: 3.147

9.  Utilizing reliable and clinically significant change criteria to assess for the development of depression during smoking cessation treatment: the importance of tracking idiographic change.

Authors:  Andrew M Busch; Theodore L Wagener; Kristin L Gregor; Kevin T Ring; Belinda Borrelli
Journal:  Addict Behav       Date:  2011-07-30       Impact factor: 3.913

10.  Minimum clinically important difference for the COPD Assessment Test: a prospective analysis.

Authors:  Samantha S C Kon; Jane L Canavan; Sarah E Jones; Claire M Nolan; Amy L Clark; Mandy J Dickson; Brigitte M Haselden; Michael I Polkey; William D-C Man
Journal:  Lancet Respir Med       Date:  2014-02-04       Impact factor: 30.700

View more
  1 in total

1.  Association of electrochemical skin conductance with neuropathy in chemotherapy-treated patients.

Authors:  Fawaz Mayez Mahfouz; Susanna B Park; Tiffany Li; Hannah C Timmins; Lisa G Horvath; Michelle Harrison; Peter Grimison; Tracy King; David Goldstein; David Mizrahi
Journal:  Clin Auton Res       Date:  2022-09-21       Impact factor: 5.625

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.